semaglutide vs sglt2 GLP-1 for CKD: Which Is Better? Perspectives in weight control in

cognitive dysfunction we mean the loss of such abilities

A positive outcome would reshape the narrative and potentially reignite interest in GLP-1 RAs across neurodegenerative disorders

Some of the most common or potential side effects include: Nausea Constipation Vomiting Diarrhea Abdominal Pain Headache Indigestion Dizziness Back pain Increased Lipase or Amylase Altered taste Nasopharyngitis (common cold) Passing Gas Bloating Belching Gastroenteritis Decreased appetite Fatigue Gastroesophageal reflux disease Low blood sugar (hypoglycemia) in those with Type 2 diabetes Upset stomach These symptoms often subside as your body adjusts to the medications

Injectable medications are designed to aid in weight management and manage type 2 diabetes

This is understandable, as the field continues to prioritize data from double-blind, placebo-controlled, randomized, controlled trials (RCTs) as the benchmark for therapeutic adoption